Home068270 • KRX
add
Celltrion Inc
Previous close
₩173,800.00
Day range
₩173,500.00 - ₩175,400.00
Year range
₩131,000.00 - ₩241,000.00
Market cap
37.82T KRW
Avg Volume
604.72K
P/E ratio
64.31
Dividend yield
0.29%
In the news
Financials
Income Statement
Revenue
Net income
(KRW) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 736.98B | 23.33% |
Operating expense | 291.23B | 256.28% |
Net income | 22.44B | -86.42% |
Net profit margin | 3.04 | -89.01% |
Earnings per share | 108.00 | -90.65% |
EBITDA | 147.04B | -38.27% |
Effective tax rate | -5.54% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 920.51B | 70.38% |
Total assets | 20.15T | 228.93% |
Total liabilities | 3.15T | 70.19% |
Total equity | 17.01T | — |
Shares outstanding | 206.85M | — |
Price to book | 2.13 | — |
Return on assets | 0.19% | — |
Return on capital | 0.20% | — |
Cash Flow
Net change in cash
(KRW) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 22.44B | -86.42% |
Cash from operations | 37.02B | -75.53% |
Cash from investing | -35.36B | 57.31% |
Cash from financing | 170.41B | 237.75% |
Net change in cash | 182.74B | 448.07% |
Free cash flow | 41.33B | -67.25% |
About
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Wikipedia
CEO
Founded
2002
Website
Employees
1,074